Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors.

Bioorg Med Chem

Department of Chemistry of Natural and Microbial Products, Division of Pharmaceutical and Drug Industries, National Research Centre, Dokki, 12622 Cairo, Egypt.

Published: November 2016

A series of (benzimidazol-2-yl)-aniline (1) derivatives has been synthesized and evaluated as glycogen phosphorylase (GP) inhibitors. Kinetics studies revealed that compounds displaying a lateral heterocyclic residue with several heteroatoms (series 3 and 5) exhibited modest inhibitory properties with IC values in the 400-600μM range. Arylsulfonyl derivatives 7 (Ar: phenyl) and 9 (Ar: o-nitrophenyl) of 1 exhibited the highest activity (series 2) among the studied compounds (IC 324μM and 357μM, respectively) with stronger effect than the p-tolyl analogue 8.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2016.08.069DOI Listing

Publication Analysis

Top Keywords

glycogen phosphorylase
8
phosphorylase inhibitors
8
synthesis benzimidazol-2-ylaniline
4
benzimidazol-2-ylaniline derivatives
4
derivatives glycogen
4
inhibitors series
4
series benzimidazol-2-yl-aniline
4
benzimidazol-2-yl-aniline derivatives
4
derivatives synthesized
4
synthesized evaluated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!